Article info
PDFCurrent controversy
Quackery or quality: the ethicolegal basis for a legislative framework for medical innovation
- Correspondence to Jo Samanta, Law School, De Montfort University, The Gateway, Leicester LE1 9BH, UK; JSamanta{at}dmu.ac.uk
Citation
Quackery or quality: the ethicolegal basis for a legislative framework for medical innovation
Publication history
- Received July 13, 2014
- Revised November 9, 2014
- Accepted December 12, 2014
- First published December 31, 2014.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Towards a bioethics of innovation
- The “Saatchi bill” is mistargeted and will put vulnerable patients at risk
- Why there is no legal or medical justification for the Saatchi bill
- The “Saatchi bill” will allow responsible innovation in treatment
- The deadly business of an unregulated global stem cell industry
- New bill aims to embolden doctors to practise innovative medicine
- Compassionate and innovative treatments in children: a proposal for an ethical framework
- Ethics briefings
- The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure
- The use of multiple-criteria decision-making theory to measure students’ perceptions of high-fidelity simulation